News for Freeline Therapeutics Holdings plc (FRLN)

Syncona Ltd - London-based investor in healthcare companies - Freeline Therapeutics Holdings PLC shareholders approve acquisition by Syncona. In November, Syncona agreed to acquire all remaining...

NEW YORK, Jan. 27, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Freeline Therapeutics Holdings plc to Syncona Ltd....

NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

NEW YORK, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

London-listed Syncona Ltd has agreed to acquire Freeline Therapeutics Holdings plc (NASDAQ: FRLN) in an all-cash transaction for $6.50 per

Syncona Ltd - London-based investor in healthcare companies - Agrees to acquire all remaining stock in investee Freeline Therapeutics Holdings PLC for USD6.50 in cash per share, valuing Freeline at...

This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed higher Friday as the S&P/BNY Mellon index of...

Operator: Good morning, everyone, and welcome to the Freeline Second Quarter 2023 Financial and Business Update Conference Call. All participants will be in a listen-only mode.

Freeline Therapeutics Holdings plc (NASDAQ:NASDAQ:FRLN) Q2 2023 Results Conference Call August 15, 2023 8:00 AM ETCompany ParticipantsNaomi Aoki - Investor RelationsMichael Parini - CEO and...

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.35 A.M. ET)..

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.35 A.M. ET)..